Quick Answer
LIGAND PHARMACEUTICALS INC reported Shares Outstanding of 19.77 million shares for fiscal year 2025.
LIGAND PHARMACEUTICALS INC Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 19.77M | +3.5% |
| 2024 | 19.11M | +8.8% |
| 2023 | 17.56M | +3.6% |
| 2022 | 16.95M | +1.1% |
| 2021 | 16.77M | +4.3% |
| 2020 | 16.08M | -4.4% |
| 2019 | 16.82M | -19.0% |
| 2018 | 20.77M | -1.8% |
| 2017 | 21.15M | +1.1% |
| 2016 | 20.91M | +4.8% |
| 2015 | 19.95M | +1.9% |
| 2014 | 19.58M | -4.4% |
| 2013 | 20.47M | -3.8% |
| 2012 | 21.28M | +2.9% |
| 2011 | 20.68M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 19.66M | +4.8% | +1.3% |
| June 30, 2025 | 19.41M | +7.2% | +0.7% |
| March 31, 2025 | 19.28M | +7.5% | +0.9% |
| December 31, 2024 | 19.11M | +8.8% | +1.8% |
| September 30, 2024 | 18.76M | +7.7% | +3.6% |
| June 30, 2024 | 18.10M | +4.3% | +1.0% |
| March 31, 2024 | 17.92M | +4.6% | +2.1% |
| December 31, 2023 | 17.56M | +3.6% | +0.8% |
- LIGAND PHARMACEUTICALS INC showed an increase of +3.5% in Shares Outstanding compared to the prior fiscal year.
- Over the 2011–2025 period, LIGAND PHARMACEUTICALS INC’s shares outstanding has declined by 4.4% (from 20.68 million shares to 19.77 million shares).
- The most recent figure is from LIGAND PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: